Why a New Inhalable Lung Cancer Treatment Is So Promising Why a New Inhalable Lung Cancer Treatment Is So Promising
Study showed that exosomes (tiny spheres released by cells) can deliver potent immunotherapy to lung cancer tumors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Brain cancer-stricken father, 40, dies just weeks after fulfilling last wish to marry his partner of 17 years
Paul Jeffries, from Birmingham , received a shock glioblastoma diagnosis in 2017 after suffering a series of seizures. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2024 Category: Consumer Health News Source Type: news
RUBY:'A Huge Win' for Patients With Endometrial Cancer RUBY:'A Huge Win' for Patients With Endometrial Cancer
The RUBY trial shows that adding an immune checkpoint inhibitor to chemotherapy improved overall survival by over 1 year for women with advanced or recurrent endometrial cancer.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion
AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.#astrazeneca (Source: Reuters: Health)
Source: Reuters: Health - March 19, 2024 Category: Consumer Health News Source Type: news
Ozempic Gets the Oprah Treatment in a New TV Special
Weight-loss drugs like Ozempic, Wegovy, and Zepbound are already extremely popular: by 2030, about 10% of the U.S. population will be on one of these drugs and the category’s sales will surpass $100 billion, according to some projections. On March 18, they got another major cultural boost from Oprah Winfrey, who shared her own experience with—and support for—these medications in an ABC special called “Shame, Blame and the Weight Loss Revolution.”
[time-brightcove not-tgx=”true”]
During the special, Winfrey talked about how using one of these weight-loss drugs (she did not say w...
Source: TIME: Health - March 19, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Safety of Less-Radical Surgery for Early Cervical Cancer Gathers More Evidence
(MedPage Today) -- SAN DIEGO -- The safety of non-radical approaches to surgery in early, low-risk cervical cancer gained additional support from a new prospective study, though fertility preservation with cone biopsy also came with some cases... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 19, 2024 Category: Hematology Source Type: news
The U.S. bans most common form of asbestos, after decades of pushback from industry
More than 50 other countries have already banned the substance, which has been known to lead to lung and ovarian cancer, mesothelioma and other deadly illnesses.(Image credit: Jenny Evans) (Source: NPR Health and Science)
Source: NPR Health and Science - March 18, 2024 Category: Consumer Health News Authors: Joe Hernandez Source Type: news
The new 6G phone technology that spots skin cancer sooner
Scientists have found a new way to detect any type of skin cancer in a matter of seconds. (Source: the Mail online | Health)
Source: the Mail online | Health - March 18, 2024 Category: Consumer Health News Source Type: news
Biden Administration Finalizes Chrysotile Asbestos Ban
Joining 50 other countries that have already banned asbestos, the United States is now banning chrysotile asbestos. The Biden administration has officially finalized the ban that follows decades of calls from survivors of asbestos-related diseases, medical professionals, veterans and first responders.
Chrysotile asbestos, also known as white asbestos, continues to be imported into the U.S., particularly for use in the chloralkali industry. Anticipating a ban, imports of asbestos rose dramatically in 2022 from 100 metric tons in all of 2021 to 114 metric tons in just the first 3 months of 2022, according to the U.S. Inte...
Source: Asbestos and Mesothelioma News - March 18, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Companies Legal Support/Support Groups/Organizations Source Type: news
This Mutation Likely Saved a Colon Cancer Patient's Life
His tumor had a specific genetic makeup known as mismatch repair-deficient, present in 5% to 10% of all rectal cancer patients, meaning he might qualify for a cutting-edge immunotherapy. (Source: WebMD Health)
Source: WebMD Health - March 18, 2024 Category: Consumer Health News Source Type: news
Lunit inks two European supply contracts
Lunit has inked two European contracts to provide AI-driven software for chest x-ray and breast imaging.
The company has secured a supply contract with TeleDiag in France and the Portuguese League Against Cancer, it said. TeleDiag is France's largest teleradiology group; it will use Lunit's Insight CXR, Lunit said. The Portuguese League Against Cancer will use Lunit's Insight MMG to analyze 100,000 mammograms each year over the next three, according to the firm.
The new contracts follow two Lunit signed last week with distributors in East and Southeast Asia. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 18, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
EPA bans asbestos, a deadly carcinogen still in use decades after a partial ban was enacted
Carcinogen is still used in some chlorine bleach, brake pads and other products. (Source: ABC News: Health)
Source: ABC News: Health - March 18, 2024 Category: Consumer Health News Tags: Health Source Type: news
Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docs
(MedPage Today) -- SAN DIEGO -- As gynecologic oncology faces an existential "identity crisis," an analysis projected that new cancer patient loads per physician would fall over the next two decades.
If current trainee numbers remained stable... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - March 18, 2024 Category: OBGYN Source Type: news
GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer
Saturday, GSK plc GSK announced overall survival (OS) results from Part 1 and progression-free survival (PFS) results from Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial of Jemperli (dostarlimab) for primary advanced or recurrent endometrial cancer, paving the way for a potential label…#gskplc #gsk #rubyengoten6 #fda #jemperli #jemperlipluszejula #zejula (Source: Reuters: Health)
Source: Reuters: Health - March 18, 2024 Category: Consumer Health News Source Type: news
EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After a Partial Ban Was Enacted
WASHINGTON — The Environmental Protection Agency on Monday announced a comprehensive ban on asbestos, a carcinogen that is still used in some chlorine bleach, brake pads and other products and that kills tens of thousands of Americans every year.
The final rule marks a major expansion of EPA regulation under a landmark 2016 law that overhauled regulations governing tens of thousands of toxic chemicals in everyday products, from household cleaners to clothing and furniture.
[time-brightcove not-tgx=”true”]
The new rule would ban chrysotile asbestos, the only ongoing use of asbestos in the United Sta...
Source: TIME: Health - March 18, 2024 Category: Consumer Health News Authors: Matthew Daly/AP Tags: Uncategorized wire Source Type: news